A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...
Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an ...
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...
As India grapples with a growing burden of diabetes and lifestyle-related disorders, attention has turned to Ozempic, a ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results